Cardiovascular Prevention and Pharmacotherapy最新文献

筛选
英文 中文
Targets for rescue from fatty acid-induced lipotoxicity in pancreatic beta cells 脂肪酸诱导的胰腺细胞脂肪毒性的拯救靶点
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-04-30 DOI: 10.36011/cpp.2022.4.e9
S. Hong, Wonsae Lee
{"title":"Targets for rescue from fatty acid-induced lipotoxicity in pancreatic beta cells","authors":"S. Hong, Wonsae Lee","doi":"10.36011/cpp.2022.4.e9","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e9","url":null,"abstract":"A persistent intake of excess calories increases plasma levels of free fatty acids, particularly the saturated form that has been shown to exert toxic effects on pancreatic beta cells by inducing dysfunction and apoptosis (i.e., lipotoxicity). An insufficient supply of insulin due to beta cell failure is a major factor in the onset and progression of type 2 diabetes; therefore, it is crucial to understand the cellular mechanisms of lipotoxicity to prevent beta cell failure. Many studies on the effects of lipotoxicity have demonstrated the various factors responsible for beta cell impairment, but the mechanisms of dysfunction and apoptosis resulting from lipotoxicity have not been fully described. This review discusses lipotoxicity-induced alterations of cellular mechanisms, and assesses drugs such as incretin mimetics, thiazolidinedione, and clusterin. Understanding the molecular mechanisms of lipotoxicity-induced beta cell failure is useful in guiding the development of new therapeutic targets for diabetes treatment.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127236765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Association between reproductive aging and hypertension among Korean women 韩国女性生殖老化与高血压的关系
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-01-31 DOI: 10.36011/cpp.2022.4.e2
Eunji Kim, Youngrong Lee, H. Kim
{"title":"Association between reproductive aging and hypertension among Korean women","authors":"Eunji Kim, Youngrong Lee, H. Kim","doi":"10.36011/cpp.2022.4.e2","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e2","url":null,"abstract":"Background: Although postmenopausal women are well known to have a high prevalence of hypertension, it is unclear whether menopause itself increases blood pressure independently from the known risk factors of hypertension. This study sought to determine whether an association exists between reproductive aging, analyzed as a gradual transition, and an increased risk of hypertension among Korean women.Methods: This cross-sectional study used baseline data from 5,456 women aged 30 to 64 years who participated in the Cardiovascular and Metabolic Diseases Etiology Research Center study in Korea from 2013 to 2018. The participants’ stage of reproductive aging was assessed by a questionnaire and categorized as premenopause, perimenopause, and postmenopause. Multiple logistic regression models were used to analyze the association between menopausal status and hypertension after adjusting for age, education level, marital status, employment, household income, smoking, drinking, physical activity, body mass index, and hormone replacement therapy use.Results: The prevalence of hypertension increased with reproductive aging: 9.8% in premenopause, 25.2% in perimenopause, and 27.7% in postmenopause. The adjusted odds ratio (95% confidence interval) for having hypertension was 1.70 (1.07–2.72) for perimenopausal women and 1.14 (0.88–1.48) for postmenopausal women, compared to premenopausal women. Conclusions: Our study shows that perimenopausal women are at high risk of developing hypertension. Since the menopausal transition may last months or years, blood pressure monitoring and early interventions are crucial for not only postmenopausal women, but also those in the transition.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114679911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-inflammatory effects of colchicine on coronary artery disease 秋水仙碱对冠心病的抗炎作用
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-01-31 DOI: 10.36011/cpp.2022.4.e5
Hun-Jun Park
{"title":"Anti-inflammatory effects of colchicine on coronary artery disease","authors":"Hun-Jun Park","doi":"10.36011/cpp.2022.4.e5","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e5","url":null,"abstract":"Inflammation plays a crucial role in the pathophysiology of coronary artery disease (CAD). Several types of sterile inflammation are mediated through the nucleotide-binding oligomerization domain-like receptor pyrin domain containing 3 (NLRP3) inflammasome. Colchicine has recently been shown to effectively block NLRP3 inflammasome assembly in addition to several other actions on inflammatory cells. Recent evidence also points to favorable effects of colchicine in patients with CAD, including lower levels of inflammatory markers, coronary plaque stabilization, and more favorable cardiac recovery after injury. This review focuses on the role of colchicine in the process of atherosclerosis and discusses its potential as a therapeutic option for the prevention and treatment of CAD.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133361639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic risk score: a useful clinical instrument for disease prediction and risk categorization 多基因风险评分:一种有用的疾病预测和风险分类的临床工具
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-01-31 DOI: 10.36011/cpp.2022.4.e7
J. Yun
{"title":"Polygenic risk score: a useful clinical instrument for disease prediction and risk categorization","authors":"J. Yun","doi":"10.36011/cpp.2022.4.e7","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e7","url":null,"abstract":"Genetic information is one of the essential components of precision medicine. Over the past decade, substantial progress has been made, such as low-cost, high-throughput genotyping arrays, advances in statistical techniques, and progressively larger discovery datasets, enabling the discovery of alleles contributing to common diseases, such as coronary artery disease and type 2 diabetes. The polygenic risk score (PRS) represents the aggregate contribution of numerous common genetic variants, individually conferring small to moderate effects, and can be used as a marker of genetic risk for major chronic diseases. PRSs can be obtained from early childhood, and only one measurement is needed to determine the score. PRSs can potentially be used for triage of further investigations to confirm disease susceptibility and to optimize individualized preventive strategies for high-risk disease groups. We provide an overview and commentary on important advances in deriving and validating PRSs, as well as the implementation of PRSs for clinically useful purposes.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131462227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of low-dose aspirin in patients with coronary artery spasm: long-term clinical follow-up 低剂量阿司匹林治疗冠状动脉痉挛的安全性和有效性:长期临床随访
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-01-31 DOI: 10.36011/cpp.2022.4.e6
B. Choi, Kyung-Hee Kim, S. Rha
{"title":"Safety and efficacy of low-dose aspirin in patients with coronary artery spasm: long-term clinical follow-up","authors":"B. Choi, Kyung-Hee Kim, S. Rha","doi":"10.36011/cpp.2022.4.e6","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e6","url":null,"abstract":"Background: Aspirin is known to aggravate coronary artery spasm (CAS) regardless of the dose (100–325 mg/day). However, it is unclear whether low-dose aspirin (LDA; 100 mg) has deleterious impacts on the clinical course of CAS patients in the long-term. Thus, we investigated the impact of LDA on the long-term clinical outcomes of CAS patients.Methods: A total of 5,697 consecutive patients without significant coronary artery disease who underwent an acetylcholine provocation test from November 2004 to May 2015 were enrolled. Of these patients, 3,072 CAS patients were enrolled in the study and divided into two groups based on whether they took LDA: the LDA group (n=338) and the non-LDA group (n=2,734). All CAS patients were prescribed anti-anginal medication as appropriate. To adjust for any potential confounders that could cause bias, a propensity score matching analysis was performed using a logistic regression model. Results: After propensity score matching, two propensity-matched groups (524 pairs, 1,048 patients, C-statistic=0.827) were generated, and the baseline characteristics of the two groups were balanced. The two groups were showed no significant differences in any follow-up events, such as major adverse cardiac events and recurrent angina.Conclusions: The main finding of the present study is that the use of LDA did not affect cardiovascular events up to 5 years in CAS patients. Therefore, the prescription of LDA in these patients should be individualized considering their clinical status.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131703408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse effects of statin therapy and their treatment 他汀类药物治疗的不良反应及其治疗
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-01-31 DOI: 10.36011/cpp.2022.4.e4
D. Cheon, S. Jo
{"title":"Adverse effects of statin therapy and their treatment","authors":"D. Cheon, S. Jo","doi":"10.36011/cpp.2022.4.e4","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e4","url":null,"abstract":"Statins are one of the most widely used drugs worldwide as first-line drugs for the treatment of hyperlipidemia and the prevention and treatment of cardiovascular diseases. Most of the side effects of statins are known to be mild, and mainly hepatotoxicity and various muscle symptoms are known. Recently, there have been studies on concerns about an increase in the incidence of diabetes after using statins, but it was found that the benefits sufficiently outweigh the risk of side effects. Therefore, the use of statins in the appropriate group should be actively performed, and it seems that the side effects can be prevented through close physical observation and appropriate examination.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126676095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Indirect comparison of nonvitamin K oral anticoagulants and left atrial appendage occlusion 非维生素K口服抗凝剂与左心耳闭塞的间接比较
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-01-31 DOI: 10.36011/cpp.2022.4.e1
Sung-Hwan Kim, So-Yoon Park, Seung-Sik Hwang
{"title":"Indirect comparison of nonvitamin K oral anticoagulants and left atrial appendage occlusion","authors":"Sung-Hwan Kim, So-Yoon Park, Seung-Sik Hwang","doi":"10.36011/cpp.2022.4.e1","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e1","url":null,"abstract":"Background: Anticoagulation is important in atrial fibrillation (AF) patients to reduce the occurrence of thrombotic events. We evaluated the efficacy and safety of percutaneous left atrial appendage occlusion (LAAO) as an alternative to systemic anticoagulation through an indirect comparative analysis.Methods: An indirect comparative analysis of nonvitamin K oral anticoagulants (NOACs) and LAAO was conducted. Comparisons were made using data from four landmark randomized clinical trials (RE-LY, ROCKET-AF, ARISTOTLE, and PROTECT AF). Using warfarin as the common comparator, an indirect comparison was performed using data from each trial, and the relative risk was calculated between NOACs and LAAO.Results: NOACs and LAAO showed similar results for the reduction of stroke and systemic embolism, with a non-statistically significant trend favoring NOACs (hazard ratio [HR], 0.74; 95% confidence interval [CI], 0.37–1.46 for dabigatran; HR, 0.99; 95% CI, 0.50–1.92 for rivaroxaban; HR, 0.89; 95% CI, 0.45–1.74 for apixaban). Significantly fewer major bleeding and procedure-related complications were found in patients treated with apixaban compared with LAAO (HR, 0.45; 95% CI, 0.26–0.75). Cardiovascular death occurred more frequently in patients administered NOACs than in patients with LAAO (HR, 2.28; 95% CI, 1.03–5.10 for dabigatran; HR, 2.41; 95% CI, 1.09–5.42 for rivaroxaban; HR, 2.40; 95% CI, 1.10–5.36 for apixaban). Conclusions: The rate of all-cause death was similar between NOACs and LAAO. Compared with LAAO, NOACs led to a nonsignificant numerical decrease in stroke and embolism in AF patients. Significantly fewer safety events occurred in patients treated with apixaban. LAAO significantly reduced cardiovascular death.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"98 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132482673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of physical activity on cardiovascular outcomes and mortality in Korean patients with diabetes: a nationwide population-based cohort study 体育活动对韩国糖尿病患者心血管结局和死亡率的影响:一项基于全国人群的队列研究
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2022-01-31 DOI: 10.36011/cpp.2022.4.e3
Inha Jung, Sun Joon Moon, Hyemi Kwon, Se Eun Park, K. Han, E. Rhee, Won-Young Lee
{"title":"Effects of physical activity on cardiovascular outcomes and mortality in Korean patients with diabetes: a nationwide population-based cohort study","authors":"Inha Jung, Sun Joon Moon, Hyemi Kwon, Se Eun Park, K. Han, E. Rhee, Won-Young Lee","doi":"10.36011/cpp.2022.4.e3","DOIUrl":"https://doi.org/10.36011/cpp.2022.4.e3","url":null,"abstract":"Background: Since a sedentary lifestyle is considered a modifiable risk factor for cardiovascular disease (CVD), physical activity (PA) is recommended for type 2 diabetes mellitus (T2DM) patients to prevent CVD. We investigated the association between different levels of PA and the risk for CVD and all-cause mortality in patients with T2DM using nationwide data. Methods: We examined health examination data and claims records of 2,745,637 participants with T2DM at baseline from the Korean National Health Insurance Service who underwent health examinations between 2009 and 2012. We excluded subjects with a history of myocardial infarction or stroke. Each participant was asked to report their weekly PA levels according to three categories: vigorous, moderate, and walking. The incidence of CVD and death was analyzed until 2017.Results: The risk of CVD was lower in regular exercisers than in nonexercisers after adjusting for confounding variables. A dose-response trend was evident in the association between the degree of PA and CVD risk. All categories of PA were inversely associated with CVD risk and mortality. The reduction in CVD risk and all-cause mortality was more profound in patients aged ≥65 years. Conclusions: Augmenting PA might have positive effects on the prevention of CVD and all-cause death, especially in the elderly. The benefits of PA were consistently observed in various subgroups regardless of the presence of chronic conditions. Therefore, clinicians should encourage elderly patients with T2DM to increase their daily PA.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132592307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Myocardial Infarction Location and In-Hospital Mortality in Iran: A Nationwide Study 伊朗心肌梗死部位与住院死亡率之间的关系:一项全国性研究
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2021-10-31 DOI: 10.36011/cpp.2021.3.e16
Mohammad Shahbaz, S. Nazari, Amineh Salehipour, R. Karimi
{"title":"Association between Myocardial Infarction Location and In-Hospital Mortality in Iran: A Nationwide Study","authors":"Mohammad Shahbaz, S. Nazari, Amineh Salehipour, R. Karimi","doi":"10.36011/cpp.2021.3.e16","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e16","url":null,"abstract":"Background: Myocardial infarction (MI) is one of the most important health problems in the world, including Iran. The rate of in-hospital mortality in MI patients ranges from 7.7% to 19.2% in different countries. Despite the promotion and utilization of new therapeutic approaches, MI-related morbidity and mortality have remained high . The recognition of risk factors for MI-related mortality plays an important role in reducing post-MI mortality. Methods: In this study, we used national MI registry data. In total, 33,831 patients who had been hospitalized in the coronary care unit of Iranian hospitals from 2012 to 2014 were analyzed. Using multivariable logistic regression, we estimated the impact of various risk factors on in-hospital mortality after MI. Results: The in-hospital mortality rate in patients with ST-elevation MI was higher than that of patients with non–ST-elevation MI. In-hospital mortality was most strongly associated with left-location MI (odds ratio [OR] relative to the non-ST-elevation MI group, 2.15), in comparison with middle-location MI (OR, 1.47) and right-location MI (OR, 1.43). Ventricular fibrillation (OR, 7.7) and ventricular tachycardia (OR, 2.78) were predictors of in-hospital mortality. Receiving treatment reduced the odds of death and age, sex, and diabetes were risk factors associated with in-hospital mortality after MI. Conclusions: Age, sex, right bundle branch block arrhythmia, atrial fibrillation, ventricular tachycardia, left bundle branch block arrhythmia, ventricular fibrillation, dyspnea, diabetes, and ST-elevation MI were associated with increased ORs for mortality after MI. Thus, patients with these factors require special attention during hospitalization.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128704676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceptron: Basic Principles of Deep Neural Networks 感知器:深度神经网络的基本原理
Cardiovascular Prevention and Pharmacotherapy Pub Date : 2021-07-01 DOI: 10.36011/cpp.2021.3.e9
Eung-Hee Kim, Hun‐Sung Kim
{"title":"Perceptron: Basic Principles of Deep Neural Networks","authors":"Eung-Hee Kim, Hun‐Sung Kim","doi":"10.36011/cpp.2021.3.e9","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e9","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"115 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124561748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书